88
Participants
Start Date
December 31, 2003
Primary Completion Date
November 30, 2008
Study Completion Date
November 30, 2008
Docetaxel
Docetaxel at the dose of 75mg/m\^2 IV on day 1 every 3 weeks for 6 consecutive cycles
Carboplatin
Carboplatin at the dose of 5 AUC IV on day 1 every 3 weeks for 6 consecutive cycles
Herceptin
Herceptin 8 mg/Kg on day 1 for the first cycle and 6 mg/Kg for the 5 remaining cycles, IV, every 3 weeks
Vinorelbine
Vinorelbine at the dose of 60mg/m\^2 per os,weekly
University Hospital of Crete, Heraklion
University General Hospital of Alexandroupolis, Dep of Medical Oncology, Alexandroupoli
"IASO General Hospital of Athens, 1st Dep of Medical Oncology", Athens
"Laikon General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine", Athens
401 Military Hospital of Athens, Athens
Air Forces Military Hospital of Athens, Athens
"Marika Iliadis Hospital of Athens, Dep of Medical Oncology", Athens
State General Hospital of Larissa, Athens
"Metaxa's Anticancer Hospital of Piraeus, 1st Dep of Medical Oncology", Piraeus
"Theagenion Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology", Thessaloniki
Lead Sponsor
University Hospital of Crete
OTHER
Hellenic Oncology Research Group
OTHER